Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E. Thervet E, et al. Among authors: pilmore h. Transplantation. 2003 Sep 27;76(6):903-8. doi: 10.1097/01.TP.0000089006.00653.64. Transplantation. 2003. PMID: 14508352 Clinical Trial.
Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study.
Stefoni S, Midtved K, Cole E, Thervet E, Cockfield S, Buchler M, Toselli L, Pallardo LM, Schena FP, Pilmore H, Kessler M, Chadban S, Carreño CA; MO2ART Study Group. Stefoni S, et al. Among authors: pilmore h. Transplantation. 2005 Mar 15;79(5):577-83. doi: 10.1097/01.tp.0000153158.91683.34. Transplantation. 2005. PMID: 15753847 Clinical Trial.
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.
Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ; ASCERTAIN Investigators. Holdaas H, et al. Transplantation. 2011 Aug 27;92(4):410-8. doi: 10.1097/TP.0b013e318224c12d. Transplantation. 2011. PMID: 21697773 Clinical Trial.
KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients.
Chadban SJ, Barraclough KA, Campbell SB, Clark CJ, Coates PT, Cohney SJ, Cross NB, Eris JM, Henderson L, Howell MR, Isbel NM, Kanellis J, Kotwal SS, Manley P, Masterson R, Mulley W, Murali K, O'Connell P, Pilmore H, Rogers N, Russ GR, Walker RG, Webster AC, Wiggins KJ, Wong G, Wyburn KR; Kidney Health Australia Caring for Australians with Renal Impairment (KHA-CARI). Chadban SJ, et al. Among authors: pilmore h. Nephrology (Carlton). 2012 Mar;17(3):204-14. doi: 10.1111/j.1440-1797.2011.01559.x. Nephrology (Carlton). 2012. PMID: 22212251 No abstract available.
103 results